X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
hypertension (8) 8
mortality (8) 8
hypertension - drug therapy (6) 6
aged (5) 5
female (5) 5
heart attacks (5) 5
index medicus (5) 5
male (5) 5
middle aged (5) 5
risk factors (5) 5
blood pressure - drug effects (4) 4
cardiovascular disease (4) 4
drug therapy (4) 4
medical and health sciences (4) 4
medicin och hälsovetenskap (4) 4
medicine, general & internal (4) 4
risk (4) 4
studies (4) 4
adult (3) 3
age (3) 3
antihypertensive agents - administration & dosage (3) 3
antihypertensive agents - adverse effects (3) 3
blood pressure (3) 3
blood-pressure (3) 3
calcium channel blockers - adverse effects (3) 3
cardiovascular diseases - prevention & control (3) 3
confidence intervals (3) 3
coronary heart disease (3) 3
drug therapy, combination (3) 3
drugs (3) 3
health aspects (3) 3
health risk assessment (3) 3
medical treatment (3) 3
morbidity (3) 3
prevention (3) 3
randomized controlled trials as topic (3) 3
risk assessment (3) 3
survival analysis (3) 3
amlodipine - adverse effects (2) 2
angiotensin-converting enzyme inhibitors - administration & dosage (2) 2
antihypertensive agents - therapeutic use (2) 2
antihypertensive drugs (2) 2
blood (2) 2
blood pressure/drug effects (2) 2
body mass index (2) 2
calcium channel blockers - administration & dosage (2) 2
cardiac and cardiovascular systems (2) 2
cardiovascular diseases (2) 2
cholesterol (2) 2
cholesterol - blood (2) 2
clinical trials (2) 2
combination (2) 2
coronary disease - prevention & control (2) 2
disease (2) 2
diuretics (2) 2
dosage and administration (2) 2
double-blind (2) 2
end-point reduction (2) 2
evaluation (2) 2
genomes (2) 2
guidelines (2) 2
heart failure (2) 2
hypertension - complications (2) 2
hypertension - diagnosis (2) 2
hypertension - physiopathology (2) 2
intervention (2) 2
kardiologi (2) 2
men (2) 2
peripheral vascular disease (2) 2
population (2) 2
potassium (2) 2
risk-factors (2) 2
stroke (2) 2
treatment outcome (2) 2
abridged index medicus (1) 1
ace inhibitors (1) 1
acute myocardial-infarction (1) 1
adjustment (1) 1
adrenergic beta-antagonists - administration & dosage (1) 1
adrenergic beta-antagonists - adverse effects (1) 1
adrenergic beta-antagonists/administration & dosage/adverse effects (1) 1
adults (1) 1
alleles (1) 1
american heart association (1) 1
amlodipine - administration & dosage (1) 1
amlodipine - therapeutic use (1) 1
amlodipine/administration & dosage/adverse effects (1) 1
angina pectoris (1) 1
angioplasty (1) 1
angiotensin (1) 1
angiotensin ii type 1 receptor blockers (1) 1
angiotensin receptor antagonists - administration & dosage (1) 1
angiotensin receptor antagonists - adverse effects (1) 1
angiotensin receptor blockers (1) 1
angiotensin type 1 receptor (1) 1
angiotensin-converting enzyme inhibitors (1) 1
angiotensin-converting enzyme inhibitors - adverse effects (1) 1
angiotensin-converting enzyme inhibitors - therapeutic use (1) 1
angiotensin-converting enzyme inhibitors/administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 05/2010, Volume 55, Issue 21, pp. 2299 - 2307
Journal Article
PLoS genetics, ISSN 1553-7390, 10/2010, Volume 6, Issue 10, pp. 1 - 11
Journal Article
The Lancet, ISSN 0140-6736, 06/2004, Volume 363, Issue 9426, pp. 2022 - 2031
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial was designed to test the hypothesis that for the same blood-pressure control, valsartan... 
CALCIUM-CHANNEL BLOCKER | LIPID-LOWERING TREATMENT | RECEPTOR BLOCKER | MEDICINE, GENERAL & INTERNAL | ISOLATED SYSTOLIC HYPERTENSION | CONVERTING-ENZYME-INHIBITOR | DOUBLE-BLIND | ANGIOTENSIN-II | ELECTROCARDIOGRAPHIC IDENTIFICATION | CORONARY-ARTERY-DISEASE | BLOOD-PRESSURE | Calcium Channel Blockers - adverse effects | Valsartan | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - therapeutic use | Angiotensin II Type 1 Receptor Blockers | Endpoint Determination | Diuretics | Female | Blood Pressure - drug effects | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Amlodipine - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Tetrazoles - adverse effects | Valine - adverse effects | Hydrochlorothiazide - therapeutic use | Hypertension | Medical research | Side effects | Drug therapy | Drugs | Heart attacks | Heart surgery | Angioplasty | Risk | Cardiovascular disease | Evidence-based medicine | Blood | Randomization | Measurement techniques | Blood pressure | Heart diseases | Age | Heart failure | Edema | Stroke | Mortality | Medical treatment | Health risks | Angina pectoris | Patients | Coronary artery disease | Morbidity | Hypotheses | Coronary vessels | Diabetes | Cardiovascular diseases | Health risk assessment | Mercury | ACE inhibitors
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 907 - 913
Results of the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) show significantly lower rates of coronary and stroke events... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | PREDICTOR | CHOLESTEROL | CORONARY | DISEASE | MEN | PREVENTION | ADULTS | RISK | COHORT | Heart Rate | Cardiovascular Diseases - physiopathology | Body Weight | Blood Glucose - analysis | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Randomized Controlled Trials as Topic | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Creatinine - blood | Adult | Potassium - blood | Aged | Blood Pressure - drug effects | Drug Therapy, Combination | Hypertension | Complications and side effects | Evaluation | Patient outcomes | Antihypertensive drugs | Drug therapy | Cardiovascular diseases | Control | Dosage and administration | Blood pressure | Diagnosis | Drug therapy, Combination | Health aspects | Coronary heart disease | Drugs | Cardiology | Medical treatment | Tests | Stroke | Statistical analysis | Adjustment | Cardiovascular disease | Triglycerides | Glucose | Regression analysis | Atenolol | Blood | Cholesterol | Risk factors | Heart rate | Matching | Variables | Regression models | Potassium | Lipoproteins (high density) | Antihypertensive Agents/administration & dosage | Drug Therapy | MEDICIN OCH HÄLSOVETENSKAP | Cardiovascular Diseases/epidemiology/physiopathology/prevention & control | Creatinine/blood | Blood Glucose/analysis | Potassium/blood | Cholesterol/blood | Randomized Controlled Trials | Blood Pressure/drug effects | Combination | Triglycerides/blood | MEDICAL AND HEALTH SCIENCES | Hypertension/drug therapy
Journal Article
The Lancet, ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | MORBIDITY | DISEASE | GUIDELINES | DOUBLE-BLIND | CALCIUM-ANTAGONISTS | HYPERTENSION | INTERVENTION | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
Blood Pressure, ISSN 0803-7051, 2009, Volume 18, Issue 6, pp. 308 - 347
Journal Article